US and Europe Gene Editing Market Share and Forecast by 2030
US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology [CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others], Product and Service (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others)
- Status : Published
- Report Code : TIPRE00029986
- Category : Life Sciences
- No. of Pages : 146
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Product and Service, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The US and Europe gene editing market majorly consists of the players such as Thermo Fisher Scientific Inc.; Merck KGaA; Lonza; PerkinElmer.; Integrated DNA Technologies; GenScript; New England Biolabs; Eurofins Scientific; CRISPR Therapeutics; Editas Medicine; and ElevateBio among others.
The factors that are driving the growth of market are the rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools. On the other hand, high cost of production of gene editing methods is likely to hinder the growth of the market during the forecast period.
Gene editing technique is utilized for the changes that are to be done in the DNA of a cell or an organism. The technique involves cutting DNA sequences for the addition or removing the DNA in the genome. The changes in the genome are done for the required characteristics of the cell. Genome editing is done for the research purpose, the treatment of the diseases, and the biotechnological purpose.
The US and Europe gene editing market is analyzed in the basis of technology, product and services, application, end user. Based on product, is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US and Europe Gene Editing Market– By Technology
1.3.2 US and Europe Gene Editing Market– By Products and Services
1.3.3 US and Europe Gene Editing Market– By Application
1.3.4 US and Europe Gene Editing Market– By End User
1.3.5 Gene Editing Market– By Geography
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US and Europe Gene Editing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 US – PEST Analysis
4.2.2 Europe – PEST Analysis
4.3 Expert Opinions
5. Gene Editing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
5.1.2 Continuous Technological Advancements in Gene Editing Tools
5.2 Market Restraints
5.2.1 High Cost of Production of Gene Editing Methods
5.3 Market Opportunities
5.3.1 Growing Biotechnology Industry in US and Europe
5.4 Future Trends
5.4.1 Strategic Initiatives by Market Players to Develop New Products
5.5 Impact Analysis
6. Gene Editing Market – US and Europe Analysis
6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. US and Europe Gene Editing Market Analysis – By Technology
7.1 Overview
7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
7.2 CRISPR
7.2.1 Overview
7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
7.3 TALEN
7.3.1 Overview
7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
7.4 Antisense
7.4.1 Overview
7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
7.5 Zinc Finger Nucleases (ZFNs)
7.5.1 Overview
7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
8. US and Europe Gene Editing Market Analysis – By Products and Services
8.1 Overview
8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
8.2 Reagents and Consumables
8.2.1 Overview
8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
8.3 Instruments
8.3.1 Overview
8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
9. US and Europe Gene Editing Market Analysis – By Application
9.1 Overview
9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
9.2 Cell Line Engineering
9.2.1 Overview
9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.3 Genetic Engineering
9.3.1 Overview
9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.4 Diagnostic Application
9.4.1 Overview
9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
9.5 Drug Discovery
9.5.1 Overview
9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
10. US and Europe Gene Editing Market Analysis – By End User
10.1 Overview
10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Overview
10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
10.3 Academic and Research Institutes
10.3.1 Overview
10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
10.4 Contract Research Organization (CROs)
10.4.1 Overview
10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
11. US and Europe Gene Editing Market Analysis
11.1 US Gene Editing Market Revenue Forecast and Analysis
11.1.1 Overview
11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2 Europe Gene Editing Market Revenue Forecast and Analysis
11.2.1 Overview
11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
11.2.8 Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.8.1 Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.9 UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.9.1 UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.10 France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.10.1 France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.11 Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.11.1 Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.12 Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.12.1 Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.13 Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.13.1 Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in US and Europe Gene Editing Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza Group AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript Biotech Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Editas Medicine Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 ElevateBio LLC
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 Glossary of Terms
List of Tables
Table 1. US: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 2. US: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 3. US: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 4. US: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 5. Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 6. Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 7. Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 8. Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 9. Germany: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 10. Germany: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 11. Germany: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 12. Germany: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 13. UK: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 14. UK: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 15. UK: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 16. UK: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 17. France: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 18. France: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 19. France: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 20. France: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 21. Italy: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 22. Italy: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 23. Italy: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 24. Italy: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 25. Spain: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 26. Spain: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 27. Spain: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 28. Spain: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 29. Rest of Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 30. Rest of Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 31. Rest of Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 32. Rest of Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
Table 35. Glossary of Terms, Gene Editing Market
List of Figures
Figure 1. Gene Editing Market Segmentation
Figure 2. Gene Editing Market Segmentation, by Region
Figure 3. US and Europe Gene Editing Market Overview
Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
Figure 5. UK to Show Significant Growth During Forecast Period
Figure 6. US and Europe Gene Editing Market – Leading Country Markets (US$ Million)
Figure 7. US and Europe Gene Editing Market, Industry Landscape
Figure 8. US PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Gene Editing Market – Key Industry Dynamics
Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
Figure 12. US and Europe Gene Editing Market – Revenue Forecast and Analysis – 2020–2030
Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 35. US Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030
Figure 36. Europe Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030
Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
Figure 38. Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 39. UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 40. France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 41. Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 42. Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 43. Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 44. Growth Strategies in US and Europe Gene Editing Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For